Press releases
- Taro Provides Results for Year Ended March 31, 2024
- Taro to Release Full Year Results on May 20, 2024
- Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger
- Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Key statistics
On Wednesday, Taro Pharmaceutical Industries Ltd (TAL:FRA) closed at 39.00, -2.01% below its 52-week high of 39.80, set on Feb 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.00 |
---|---|
High | 39.00 |
Low | 39.00 |
Bid | 39.40 |
Offer | 39.60 |
Previous close | 39.00 |
Average volume | 18.80 |
---|---|
Shares outstanding | 37.58m |
Free float | 8.08m |
P/E (TTM) | 29.67 |
Market cap | 1.60bn USD |
EPS (TTM) | 1.43 USD |
Data delayed at least 15 minutes, as of May 22 2024 07:02 BST.
More ▼